Mounjaro (that’s tirzepatide to its mum) is brand-new, like a shiny new sports car nobody’s driven yet. New drugs cost a fortune because the company that invented them, Eli Lilly, has to recoup the billions they spent on research and development. Think of it as them saying, “We made this amazing thing, now pay us back, please.”
Plus, the NHS has a special arrangement—it’s called a Patient Access Scheme—which keeps the official price hush-hush. But if you’re buying it privately? Ouch. We’re talking £200 to £300 a month for the starting doses. That’s more than my weekly grocery bill, and I’m a fan of fancy cheese.
